COVID-19 is a fast-mutating virus. Japan is rolling out the new omicron booster shot, but the virus might still be faster.
In Japan, Daiichi Sankyo began developing an mRA vaccine about the same time as Pfizer and Moderna, but the know-how to connect this society was lacking.
A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.
Studies have shown that China’s homemade COVID-19 vaccines offer little to no protection against Omicron. With infections raging, the Games are turning into a logistical nightmare.
Investigations must be done by Moderna Inc., its Spanish partner Rovi SA, and Japan’s health ministry, and the results disclosed to the public in full.
Shionogi’s plans involve regional partners and will help supply vaccine across Asia, providing a balance to China’s expansion of its “vaccine diplomacy”.
In early July, several prefectures saw the supply of vaccines distributed to them drop. Yet, on July 8, PM Suga said “there are still 40 million...
Who qualifies to get vaccinated? In principle, all members of the population over 16 are eligible.
If Japanese vaccines can be made easily transportable and available, access to vaccinations will be broadened for a greater number of people in the developing world.
The Japanese government is now tackling vaccinations from various fronts, including the possibility of enlisting pharmacists to help out in the vaccine rollout.
By being slow with the rollout, Japan can receive updated vaccine formulas that are more effective against new, more infectious virus mutations as have emerged in...
We may learn much from DARPA’s method to develop so-called “game changer” technologies that overcome national crises like coronavirus pandemic.